PDF(Pubmed)
Abstract：
Ipsilateral axillary adenopathy post-COVID mRNA vaccine has been widely reported and guidelines for management have been established. Isolated changes of axillary tail trabecular thickening without associated adenopathy in the breast present a diagnostic dilemma and no official guidelines have thus far been reported. This finding has been reported after COVID mRNA vaccine and has never been reported with any other vaccine. We report on a patient with such changes on screening mammography 1.5 months after the fifth dose of a COVID-mRNA vaccine and 1 week after RSV vaccine. This raises the possibility that such changes can be seen with vaccines other than the COVID mRNA series of vaccines. The main differential diagnosis includes mastitis and inflammatory breast cancer. The transient nature of this finding with spontaneous resolution at diagnostic mammography and the vaccination history helps to establish the diagnosis and exclude breast cancer.
摘要：
COVIDmRNA疫苗后同侧腋窝腺病已被广泛报道，并已建立治疗指南。腋窝尾小梁增厚的孤立变化，没有相关的乳腺腺病，这是一个诊断难题，到目前为止，尚无官方指南报道。这一发现是在COVIDmRNA疫苗后报道的，从未与任何其他疫苗一起报道过。我们报告了一名患者在第五剂COVID-mRNA疫苗接种后1.5个月和RSV疫苗接种后1周时筛查乳房X线检查出现这种变化。这增加了这种变化在COVIDmRNA系列疫苗以外的疫苗中可以看到的可能性。主要鉴别诊断包括乳腺炎和炎性乳腺癌。该发现具有诊断性乳房X线照相术和疫苗接种史的自发分辨率的短暂性质有助于建立诊断并排除乳腺癌。
